191 related articles for article (PubMed ID: 31565732)
1. Quinine Enhances Photo-Inactivation of Gram-Negative Bacteria.
Leanse LG; Dong PT; Goh XS; Lu M; Cheng JX; Hooper DC; Dai T
J Infect Dis; 2020 Feb; 221(4):618-626. PubMed ID: 31565732
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies.
Wang Y; Wu X; Chen J; Amin R; Lu M; Bhayana B; Zhao J; Murray CK; Hamblin MR; Hooper DC; Dai T
J Infect Dis; 2016 May; 213(9):1380-7. PubMed ID: 26908743
[TBL] [Abstract][Full Text] [Related]
3. Quinine Improves the Fungicidal Effects of Antimicrobial Blue Light: Implications for the Treatment of Cutaneous Candidiasis.
Leanse LG; Goh XS; Dai T
Lasers Surg Med; 2020 Jul; 52(6):569-575. PubMed ID: 31746024
[TBL] [Abstract][Full Text] [Related]
4. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Konai MM; Haldar J
ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Blue Light Inactivation of Microbial Isolates in Biofilms.
Ferrer-Espada R; Wang Y; Goh XS; Dai T
Lasers Surg Med; 2020 Jun; 52(5):472-478. PubMed ID: 31536154
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for multidrug-resistant nonfermenters.
Briceño DF; Quinn JP; Villegas MV
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
9. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
[TBL] [Abstract][Full Text] [Related]
10. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.
Lood R; Winer BY; Pelzek AJ; Diez-Martinez R; Thandar M; Euler CW; Schuch R; Fischetti VA
Antimicrob Agents Chemother; 2015 Apr; 59(4):1983-91. PubMed ID: 25605353
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR)
Xiong YQ; Li L; Zhou Y; Kraus CN
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382389
[No Abstract] [Full Text] [Related]
12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
13. "Future" threat of gram-negative resistance in Singapore.
Tan TT
Ann Acad Med Singap; 2008 Oct; 37(10):884-90. PubMed ID: 19037523
[TBL] [Abstract][Full Text] [Related]
14. Effective Treatment of Cutaneous Mold Infections by Antimicrobial Blue Light That Is Potentiated by Quinine.
Leanse LG; Dos Anjos C; Wang Y; Murray CK; Hooper DC; Dai T
J Infect Dis; 2021 Sep; 224(6):1069-1076. PubMed ID: 33528496
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial blue light therapy for multidrug-resistant Acinetobacter baumannii infection in a mouse burn model: implications for prophylaxis and treatment of combat-related wound infections.
Zhang Y; Zhu Y; Gupta A; Huang Y; Murray CK; Vrahas MS; Sherwood ME; Baer DG; Hamblin MR; Dai T
J Infect Dis; 2014 Jun; 209(12):1963-71. PubMed ID: 24381206
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet C light for Acinetobacter baumannii wound infections in mice: potential use for battlefield wound decontamination?
Dai T; Murray CK; Vrahas MS; Baer DG; Tegos GP; Hamblin MR
J Trauma Acute Care Surg; 2012 Sep; 73(3):661-7. PubMed ID: 22929495
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of photodynamic therapy in combination with colistin against a pan-drug resistant Acinetobacter baumannii isolated from burn patient.
Boluki E; Kazemian H; Peeridogaheh H; Alikhani MY; Shahabi S; Beytollahi L; Ghorbanzadeh R
Photodiagnosis Photodyn Ther; 2017 Jun; 18():1-5. PubMed ID: 28088439
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
Ušjak D; Ivković B; Božić DD; Bošković L; Milenković M
Microb Pathog; 2019 Jun; 131():186-196. PubMed ID: 30980878
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
20. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
Navon-Venezia S; Ben-Ami R; Carmeli Y
Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
